Every person’s tumour is unique due to the different types of cancer DNA mutations acquired during the development of the cancer so treatments do not work for everyone.
DNA Molecular Profiling makes it possible to find out which therapy options among the hundreds of targeted therapies are more likely to give successful results.
This is the cornerstone of personalised medicine, the new clinical approach that uses information about a person’s DNA profile to target specific mutations in cancer.
A single DNA test on a tumour sample can increase the chance of identifying a new and successful treatment by 90%
Now covered by health insurers
“Having exhausted standard therapy for my stage 4 bowel cancer, Oncologica identified a targeted therapy, which would work on my rare genotype. After just 4 weeks of treatment, I have gone from being bedbound to swimming, walking and fully enjoying all that life has to offer again. I am truely grateful”
The clinical team provides a free consultation to advise on suitability for testing
Oncologica collects the tumour samples from the patient’s hospital
We then perform DNA/RNA sequencing on the tumour sample
Detected mutations are matched to the targeted therapies and immunotherapies most likely to provide positive results
The Oncofocus Report provides a personalised treatment profile
Oncologica® is a leading precision oncology certified laboratory based in the prestigious Chesterford Research Park, Cambridge, UK.
We have developed a revolutionary precision oncology test that helps medical professionals to select the most appropriate therapeutic choices for each of their patients.